4basebio UK Societas ("4bb" or "the Company") is a specialist life sciences group focused on therapeutic DNA for gene therapies and DNA vaccines and providing solutions for effective and safe delivery of these DNA based products to patients. Its main country of operation is the UK. It is the intention of the Company to become a market leader in the manufacture and supply of high purity, synthetic DNA for research, therapeutic and pharmacological use. The principal objective of 4bb is to validate and scale its DNA synthesis process with a view to manufacturing Good Manufacturing Practice ("GMP") grade DNA, suitable for use in gene therapies and DNA vaccines.
| CEO: |
Heikki Lanckriet |
| CFO: |
David John Roth |
| Non-Executive Director: |
Joseph Manuel Fernández, Hansjörg Plaggemars |
| Non-Executive Chairman: |
Timothy Paul McCarthy |
| Independent Non-Executive Director: |
Maria Del Pilar de la Huerta, Alan Malus |
| Chief Operating Officer: |
Amy Walker |
| Address: |
25 Norman Way, Over, Cambridge, United Kingdom |
| Phone: |
+44 (0)1223 967943 |
| Fax: |
|
| Website: |
http://www.4basebio.com/ |
| Email: |
|